Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-746-1 | CAS number: 87-44-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Study was conducted similar to OECD Guideline 487, however there was no metabolic activation.
- Justification for type of information:
- Mutagenicity refers to the induction of permanent transmissible changes in the amount or structure of genetic material of cells or organisms. The Bacterial Reverse Mutation Test (OECD 471, EU B.13/14) is required to fulfil Annex VII information requirements on mutagenicity. Genotoxicity is a broader term to processes which alter the structure, information content or segregation of DNA, that are not necessarily associated with mutagenicity. In order capture broader mechanisms of genetic toxicity, an assessment of cytogenicity or micronucleus formation is required to fulfil REACH Annex VIII-X information requirements. However, all existing available information should be evaluated, including any in vitro and in vivo data exceeding the tonnage requirements.
Data source
Reference
- Reference Type:
- publication
- Title:
- Inhibition by β-caryophyllene of ethyl methanesulfonate-induced clastogenicity in cultured human lymphocytes
- Author:
- Di Sotto A, Mazzanti G, Carbone F, Hrelia P, Maffei F
- Year:
- 2 010
- Bibliographic source:
- Mutation Research, 699, 23-28
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Deviations:
- yes
- Remarks:
- No metabolic activation.
- Principles of method if other than guideline:
- - Principle of test: The clastogenicity test was performed by the cytokinesis-block technique using human lymphocytes.
- Short description of test conditions: Lymphocytes were cultivated for 48 hours and were supplemented with cytochalasin-B at 44 hours. At 48 hours of cultivation, the lymphocytes were treated with the test item concentrations. After 72 hours of exposure, cells were fixed and stained and analysed under a light microscope.
- Parameters analysed / observed: Nuclear mitotic index and micronucleus frequency - GLP compliance:
- not specified
- Remarks:
- Study was performed in a university research laboratory.
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Caryophyllene
- EC Number:
- 201-746-1
- EC Name:
- Caryophyllene
- Cas Number:
- 87-44-5
- Molecular formula:
- C15H24
- IUPAC Name:
- (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source of test material: Sigma-Aldrich Co (St. Louis, MO, USA)
- Purity: ≥98.5%
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: human
- Details on mammalian cell type (if applicable):
- CELLS USED
- Suitability of cells: Peripheral lymphocytes
- Sex, age and number of blood donors: Healthy, non-smoking males, less than 40 years old
- Whether whole blood or separated lymphocytes were used: Lymphocytes were separated from whole blood by using a density gradient.
- Methods for maintenance in cell culture: Lymphocytes were cultured at a concentration of 2E6 cells in 5 mL RPMI 1640 medium supplemented with 15% foetal calf serum (FCS), 1% phytohaemagglutinin (PHA), 1% penicillin–streptomycin solution and 1 mM l-glutamine.
MEDIA USED
- Type and identity of media: The cultures were incubated in RPMI 1640 medium at 37°C in a wet, 5% CO2 atmosphere. - Additional strain / cell type characteristics:
- not applicable
- Cytokinesis block (if used):
- Yes, 3 µg/mL cytochalasin-B was added after cultivation for 44 hours
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 1, 5, 10, 50, 100 and 200 µg/mL
The highest concentration at which neither necrosis nor cytotoxic or cytostatic effects were observed in the preliminary cytotoxicity test was used as the maximum concentration in the clastogenicity test. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Ethanol/distilled water (50% v/v)
- Justification for choice of solvent/vehicle: Test substance was dissolved in vehicle in order to avoid precipitation of the substance in the medium.
Controls
- Untreated negative controls:
- yes
- Remarks:
- sterile DMSO
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- other: colcemide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 48 hours, 3 µg/mL cytochalasin-B was added after cultivation for 44 hours
- Exposure duration: 72 hours
- Fixation time (start of exposure up to fixation or harvest of cells): 72 hours
STAIN: Conventional May-Grünwald–Giemsa stain
NUMBER OF REPLICATIONS: The experiments were repeated at least twice, and in each experiment, each concentration was tested in two parallel cultures; data from the two experiments were pooled.
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: At the end of the 72-h incubation period, the lymphocytes were collected, treated with a mild hypotonic solution (1:2 RPMI 1640 medium/H2O, supplemented with 2% FCS) for 2 min and then fixed in ice-cold acetic acid:methanol (1:1). After fixation, the cells were put directly onto slides by use of a cytospin centrifuge, air-dried and stained with conventional May-Grünwald–Giemsa stain.
NUMBER OF CELLS EVALUATED: At least 1000 lymphocytes were scored for each dose and at least 2000 binucleated cells (BNCs; 1000 for each culture) were examined for the presence of one, two or more micronuclei. All slides were coded and scored with a light microscope at 1000× magnification under oil immersion.
DETERMINATION OF CYTOTOXICITY
- Method: Nuclear division index (NDI)
- Any supplementary information relevant to cytotoxicity: NDI was determined by scoring at least 1000 cells per dose for the presence of one, two, three or more nuclei and calculated as follows: NDI = (1M1+2M2+3M3+4M4)/n, where M1–M4 indicates the number of cells with 1–4 nuclei and n indicates the total number of cells scored. The percent NDI of treated cells (NDIt) was calculated with respect to the control (NDIc). - Evaluation criteria:
- NDI and MN were evaluated according to the criteria described by Fenech (2007).
- Statistics:
- The one-way analysis of variance (one-way ANOVA), followed by Dunnett’s Multiple Comparison Post Test, was used to verify significant differences between treatments (P<0.05).
Results and discussion
Test results
- Key result
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not examined
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES: At concentrations of 1, 5, 10, 50, and 100 µg/mL, β-caryophyllene did not induce any cytotoxic effect and did not affect the NDI, so these cultures were evaluated for the presence of micronuclei. A significant reduction (34%) in NDI with respect to the control was observed in the human lymphocyte cultures treated with β-caryophyllene at the highest concentration tested (200 µg/mL).
NUMBER OF CELLS WITH MICRONUCLEI
- Number of cells for each treated and control culture: See figure in attachment.
Applicant's summary and conclusion
- Conclusions:
- No significant genotoxic effects, in terms of an increase in MN frequency, were observed at concentrations up to 100 µg/mL. β-caryophyllene did not induce any cytotoxic effects and did not affect the NDI at concentrations up to 100 µg/mL.
- Executive summary:
The clastogenicity and cytotoxicity of beta-caryophyllene was determined in the in vitro micronucleus assay in human lymphocytes (2010). Peripheral lymphocytes obtained from healthy, non-smoking males under 40 years of age were cultured in supplemented RPMI 1640 culture medium, to investigate the mechanisms of action of β-Caryophyllene (1, 5, 10, 50 and 100 µg/mL) treatment before (pre-treatment), during (co-treatment) and after (post-treatment) treatment with the mutagens. The study was conducted using the cytokinesis-block technique and included a negative and positive control. Cells were stained using conventional May-Grünwald–Giemsa stain and were analysed with a light microscope.
Up to 100 µg/mL β-Caryophyllene did not produce cytotoxicity or genotoxic effects, as demonstrated by the nuclear division index (NDI) and frequency of micronuclei (MN). A significant reduction (34%) in nuclear division index with respect to the control was observed at the highest concentration tested (200 µg/mL). Classified as a genotoxic agent, ethyl methanesulfonate (EMS) alkylates DNA and induces chromosomal aberrations. β-Caryophyllene significantly reduced the MN frequency in EMS treated cells, protecting against the clastogenic effects of EMS in both pre- and co-treatment protocols. Comparable to an OECD 487 study and published in a peer-reviewed journal, this study is considered reliable with restriction (Klimisch 2).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.